Angina Treatments

Find Angina Treatments

Generic Name

Isosorbide

Brand Names

Isordil Titradose, BiDil

FDA approval date: December 01, 1978

Classification: Nitrate Vasodilator

Form: Tablet

What is Isordil Titradose (Isosorbide)?

Isosorbide dinitrate tablets are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of immediate-release oral isosorbide dinitrate is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

A Randomized, Double-blind, Placebo Controlled Study (DANHEART): Hydralazine-ISDN in Patients With Chronic Heart Failure - Hydralazine Heart Failure Trial (H-HeFT) and Metformin in Patients With Chronic Heart Failure and Diabetes or Insulin Resistance - Metformin Heart Failure Trial (Met-HeFT)

Who is this study for: Patients with Heart Failure, Diabetes

Enrollment Status: Recruiting

Publish Date: December 10, 2025

Intervention Type: Drug

Study Drugs: Hydralazine Isosorbide Dinitrate, Metformin Hydrochloride

Study Phase: Phase 4

Summary: The present study is testing in a combined design to types of drugs in patients with chronic heart failure: 1) Hydralazine in combination with isosorbide dinitrate (BiDil) and 2) Metformin hydrochloride. The study is double blind, placebo controlled. 1. The first hypothesis is that hydralazine in combination with isosorbide dinitrate can reduce mortality and hospitalization with worsening heart fa...

Antiplatelet Therapy and Endothelial-stabilizing Agents in Cerebral Small Vessel Diseases

Enrollment Status: Recruiting

Publish Date: March 28, 2025

Intervention Type: Drug

Summary: Cerebral small vessel disease (cSVD) is a common accompaniment of aging. Recent small subcortical (or lacunar) infarcts (i.e. symptomatic cSVD) and white matter hyperintensities are typical cSVD lesions on neuroimaging. cSVD causes about a quarter of ischaemic strokes and related with cognitive dysfunction. However, few studies are available so far to especially explore the treatment of cSVD. Endo...

Vasodilation or Loop-diuretics for Initial Treatment of Pulmonary Edema or Congestion Due to Acute Heart Failure - a Randomized Placebo-controlled Trial

Who is this study for: Patients with Pulmonary Edema, Congestive Heart Failure, Acute Heart Failure

Enrollment Status: Recruiting

Publish Date: December 19, 2024

Intervention Type: Drug

Study Drugs: Furosemide Injection, Isosorbide Dinitrate, Furosemide and Isosorbide Dinitrate

Study Phase: Phase 4

Background: Intravenous (IV) loop-diuretics have been a key component in treating pulmonary edema since the nineteen sixties and has a Class 1 recommendation in the 2021 European Society of Cardiology guidelines for heart failure. Conversely, vasodilation was downgraded in the treatment of acute heart failure due to a lack of trials that compare vasodilation with loop-diuretics in a hyperacute clinical settin...

View All Clinical Trials